Aldose Reductase: An Emerging Target for Development of Interventions for Diabetic Cardiovascular Complications

Diabetes is a leading cause of cardiovascular morbidity and mortality. Despite numerous treatments for cardiovascular disease (CVD), for patients with diabetes, these therapies provide less benefit for protection from CVD. These considerations spur the concept that diabetes-specific, disease-modifyi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jannapureddy, Sravya, Sharma, Mira, Yepuri, Gautham, Schmidt, Ann Marie, Ramasamy, Ravichandran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992003/
https://www.ncbi.nlm.nih.gov/pubmed/33776930
http://dx.doi.org/10.3389/fendo.2021.636267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992003/
https://www.ncbi.nlm.nih.gov/pubmed/33776930
http://dx.doi.org/10.3389/fendo.2021.636267

Ejemplares similares